LEXXW vs LI · rev $705.9K vs P/E 24, rev $16.06B
Lexaria Bioscience Corp (LEXXW) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Li Auto Inc (LI) is a auto manufacturers company listed on US. It is led by Xiang Li.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
LEXXW currently screens at market cap $33.8M. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the LEXXW and LI stock pages for the full models.
Not investment advice.